IMTXW Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Jun 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 0.07% compare to its pairs and should correct upwards.

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States...

Stats
Today's Volume	1 302
Average Volume	0
Market Cap	1.26B
EPS	$-0.0311 ( Q1 \| 2024-05-14 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0280 (0.93%)

AADI -2.65%

ABCL 2.57%

ABCM 0.04%

ABEO -2.13%

ABIO -1.69%

ABOS 0.70%

ABSI 2.21%

ABUS -2.30%

ABVX -1.50%

ACAD -0.13%

ACER -17.95%

ACET -5.10%

ACGN 1.29%

ACHL -2.20%

ACHV -0.43%

ACIU -1.25%

ACLX 0.84%

ACRV -4.86%

ACST -3.58%

ACXP 1.38%

ADAG 4.64%

ADAP -3.96%

ADGI 0.87%

ADIL 0.54%

ADMA -2.50%

ADPT 0.30%

ADTX -3.47%

ADVM -2.68%

ADXN -1.60%

AEON -3.74%

AEZS -2.49%

AFMD -1.05%

AGEN -2.62%

AGIO -2.42%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -1.52%

AKRO -2.17%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -1.49%

ALEC -0.46%

ALGS -0.10%

ALKS -0.04%

ALLK -8.86%

ALLO -4.79%

ALLR -3.37%

ALNA 3.16%

ALNY 2.09%

ALPN 0.02%

ALPX 0.00%

ALRN 0.33%

ALT -9.52%

ALVR 1.83%

ALXN 0.00%

ALXO -11.26%

ALZN 1.97%

AMRN -0.73%

AMTI -3.13%

ANAB 1.68%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.98%

ANPC -3.15%

APGE -0.83%

APGN 8.48%

APGNW 30.65%

APLM -6.47%

APLS 1.11%

APLT -3.60%

APM 4.20%

APOP 0.38%

APRE 0.60%

APTO 6.12%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -4.40%

ARDS -14.23%

ARDX -0.08%

ARGX -1.03%

ARNA 0.00%

ARPO -0.90%

ARQT -0.99%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.54%

ARWR -1.23%

ASLN -5.07%

ASMB -8.31%

ASND -1.43%

ATAI -1.11%

ATHA 5.48%

ATHE 0.56%

ATHX -33.50%

ATNF 0.99%

ATOS 2.43%

ATRA -4.12%

ATXI 1.93%

ATXS -0.44%

AUPH -0.81%

AURA 1.91%

AUTL -1.58%

AVBP -1.03%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -4.14%

AVTX -1.25%

AVXL -2.59%

AXLA 0.00%

AXSM -1.28%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 2.57%

BCAB 4.58%

BCDA -2.23%

BCDAW -41.77%

BCEL 0.00%

BCLI 5.89%

BCRX 1.89%

BCTX 8.16%

BCTXW -16.32%

BCYC 0.90%

BDRX -3.85%

BDTX -0.64%

BEAM 1.24%

BFRA -2.91%

BGNE -2.65%

BIOR -5.21%

BIVI 3.03%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -2.48%

BLTE -0.62%

BLU 0.03%

BLUE -0.17%

BMEA -11.04%

BMRN 0.61%

BNOX 4.61%

BNTC -0.42%

BNTX -1.64%

BOLD -8.58%

BOLT 0.72%

BPMC -0.74%

BPTH 1.43%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 30.51%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.39%

CABA 1.31%

CADL -1.23%

CALA 0.00%

CALC -1.77%

CALT -1.14%

CAPR -2.80%

CARA 0.72%

CARM 13.04%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -5.38%

CCCC -5.31%

CCXI 0.00%

CDAK 0.00%

CDIO -2.20%

CDIOW 24.00%

CDMO -2.82%

CDMOP 0.04%

CDT -9.88%

CDTTW -39.60%

CDTX -1.31%

CDXC 0.41%

CDXS 7.41%

CELC -3.76%

CELU -0.67%

CELUW 11.80%

CERC -1.68%

CERE -1.21%

CERO -3.40%

CEROW -22.75%

CFRX -27.95%

CGEM -2.19%

CGEN -3.31%

CGON -0.98%

CGTX -4.55%

CHMA -6.00%

CHRS 0.32%

CINC 0.00%

CING -0.24%

CINGW 34.95%

CKPT -2.42%

CLBS -16.75%

CLDX -1.99%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 8.12%

CLSD 0.43%

CLSN -0.68%

CLVS 0.00%

CMMB -0.98%

CMND 2.42%

CMPI 0.00%

CMPX -5.72%

CMRA 0.00%

CMRAW 33.33%

CMRX -3.04%

CNCE 0.00%

CNSP -34.15%

CNST 0.00%

CNTA -0.67%

CNTB 0.00%

CNTX -6.85%

COCP -2.00%

COEPW 32.45%

COGT -2.16%

CORT 2.24%

COYA -1.46%

CPRX -0.92%

CRBP -3.79%

CRBU -4.47%

CRDF -0.89%

CRGX 0.64%

CRIS -1.72%

CRNX -5.82%

CRSP 1.36%

CRTX 2.63%

CRVO -2.50%

CRVS 1.80%

CSBR -1.59%

CTCX -1.60%

CTIC 0.06%

CTMX -3.31%

CTNM -2.33%

CTXR 1.95%

CUE 5.54%

CVAC -2.54%

CVKD -4.57%

CWBR 2.80%

CYAD -12.96%

CYCC 8.18%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -1.87%

CYTO -2.70%

DARE 5.14%

DAWN 0.67%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 27.83%

DNLI -0.80%

DNTH -9.24%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -2.42%

DTIL 0.56%

DYAI 10.32%

EARS -1.77%

EDIT -2.52%

EDSA 3.19%

EFTR 4.32%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.98%

ELEV -5.81%

ELOX 7.69%

ELTX -0.88%

ELVN -4.26%

ELYM 1.67%

ENGN -5.12%

ENGNW 0.00%

ENLV 2.54%

ENOB 1.79%

ENSC 5.16%

ENTA -0.12%

ENTO -2.42%

ENTX 1.60%

ENVB 1.42%

EPIX -0.31%

EPRX -2.97%

EPZM 0.00%

EQ 0.32%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.38%

ETON 2.13%

ETTX 0.00%

EVAX -2.14%

EVGN 3.97%

EVLO 0.00%

EWTX 0.06%

EXAI -0.47%

EXEL -0.22%

EYEG -0.69%

EYEN 0.95%

EYPT 0.97%

FATE -7.53%

FBIO 0.89%

FBIOP 0.92%

FBLG -14.11%

FBRX -0.04%

FDMT -3.55%

FENC -1.29%

FGEN -4.70%

FHTX 2.67%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.28%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.16%

FULC -3.51%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.28%

GANX -1.57%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -3.98%

GHRS -2.13%

GLMD -5.09%

GLPG -2.26%

GLSI 2.73%

GLTO -0.57%

GLUE -2.51%

GLYC -9.88%

GMAB -0.54%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -3.40%

GNLX 1.11%

GNPX 0.98%

GNTA 3.94%

GOSS -11.86%

GOVX 0.50%

GOVXW -49.04%

GPCR -6.88%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.06%

GRTX 2.57%

GTHX 0.46%

GUTS -4.97%

GXGXW 41.67%

GYRE -5.07%

HALO -1.13%

HARP 0.09%

HCWB -3.75%

HEPA -3.64%

HGEN -84.62%

HILS 5.66%

HLVX 0.08%

HOOK 0.00%

HOTH -2.70%

HOWL -1.50%

HRMY 0.81%

HRTX 4.27%

HSTO 0.00%

HUMA 0.41%

HUMAW -0.01%

IBRX -3.42%

ICCC 0.22%

ICPT 0.21%

ICU 17.26%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.40%

IFRX -1.80%

IGMS -0.44%

IKNA 1.19%

IKT 1.42%

IMAB 1.74%

IMCR -2.93%

IMGN 0.02%

IMGO 0.00%

IMMP 5.70%

IMMX -7.33%

IMNM -1.21%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.35%

IMTX -1.67%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.66%

INAB -0.01%

INBX 1.13%

INCY -0.89%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM 2.57%

INMB 2.53%

INO -1.69%

INSM -1.03%

INTS -2.75%

INVA 0.50%

INZY 1.14%

IOBT -11.02%

IONS 0.09%

IOVA -1.90%

IPA 0.00%

IPHA 5.58%

IPSC -1.37%

IRON -2.61%

ISEE 0.38%

ITOS -1.71%

ITRM 1.67%

IVA 6.96%

IVVD -2.07%

JAGX 1.84%

JANX -3.30%

JAZZ -0.62%

JNCE 0.00%

JSPR -6.20%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.54%

KALV -1.47%

KDNY 0.22%

KMPH -0.34%

KNSA -2.46%

KNTE -0.38%

KOD -6.72%

KPRX 0.96%

KPTI -2.30%

KRBP -10.00%

KRON 1.05%

KROS -0.94%

KRRO -8.20%

KRTX 0.03%

KRYS -0.98%

KTRA 15.61%

KTTA 8.16%

KTTAW 0.92%

KURA -1.12%

KYMR -2.44%

KYTX -4.25%

KZIA 2.65%

KZR -0.92%

LABP 0.57%

LBPH -2.02%

LBPS 0.00%

LBPSW 14.81%

LEGN 2.09%

LENZ -3.66%

LEXX 0.76%

LEXXW -14.63%

LGND -1.33%

LGNDV 0.00%

LGVN -9.91%

LIAN -8.28%

LIFE 2.70%

LIPO -11.13%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 1.65%

LPCN -2.94%

LPTX -1.10%

LQDA -0.57%

LRMR -2.63%

LSTA -4.06%

LTRN 1.37%

LUMO -1.32%

LVTX -1.03%

LXEO -4.21%

LXRX -1.47%

LYEL -33.58%

LYRA 0.93%

MACK 0.10%

MBIO -11.56%

MBRX -2.57%

MCRB 1.93%

MDGL -2.75%

MDNA -13.16%

MDWD 0.41%

MDXG -2.36%

MEIP -0.13%

MESO -2.08%

MGNX -3.15%

MGTA -7.74%

MGTX -3.33%

MGX -4.83%

MIRM -1.98%

MIRO 0.59%

MIST 0.77%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -1.06%

MLYS -6.65%

MNKD -0.76%

MNMD 0.30%

MNOV 2.11%

MNPR -5.01%

MOLN 1.79%

MOR 1.20%

MORF -2.89%

MREO -2.72%

MRKR 2.57%

MRNA -5.24%

MRNS -4.04%

MRSN -1.90%

MRTX -0.17%

MRUS 0.21%

MRVI -1.60%

MTCR -1.29%

MTEM 4.95%

MTP -18.50%

MURA -1.23%

MYMD 5.41%

NAMS 1.88%

NAMSW 0.43%

NAUT 1.77%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.82%

NERV -0.63%

NEXI 4.04%

NGM -1.28%

NGNE -1.25%

NKGN 9.24%

NKGNW 8.00%

NKTR -4.21%

NKTX -4.73%

NLSP 7.90%

NLSPW 26.67%

NMRA -1.37%

NMTR -42.97%

NOVN -24.84%

NRBO 11.50%

NRIX -0.31%

NRSN -5.12%

NRSNW 0.00%

NRXP -5.20%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -5.17%

NTRBW -31.07%

NUVL -1.14%

NVAX -2.43%

NVCT 4.55%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.13%

OABIW -10.06%

OBIO -4.67%

OBSV 0.00%

OCEA -0.70%

OCGN 4.66%

OCS -1.00%

OCUL -1.45%

OCUP 1.31%

ODT -4.27%

OKYO 1.51%

OLMA -5.63%

OMER -0.51%

OMGA 5.86%

ONCO 4.96%

ONCR -3.08%

ONCS 31.87%

ONCT -3.05%

ONCY 0.00%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 2.06%

ORGS 0.65%

ORIC -3.26%

ORMP 23.94%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.43%

OYST 0.00%

PALI 2.61%

PASG -1.30%

PBLA -7.50%

PBM -8.21%

PBYI 1.35%

PCSA 0.00%

PCVX 0.26%

PDSB -5.37%

PEPG 2.59%

PGEN -1.80%

PHAR 1.51%

PHAS 0.00%

PHAT -1.16%

PHIO -0.83%

PHIOW 36.47%

PHVS -6.81%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.10%

PLUR 5.78%

PMN 0.72%

PMVP 0.00%

PNT 0.16%

PPBT -6.84%

PRAX 1.45%

PRDS 0.93%

PRLD -3.17%

PROG -3.47%

PROK -0.45%

PRQR 0.00%

PRTA -2.11%

PRTC 0.49%

PRTG -0.54%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -8.54%

PSTX -0.39%

PTCT -0.46%

PTE -0.82%

PTGX -1.14%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 1.31%

QLGN -2.83%

QNCX 5.70%

QNRX 0.37%

QSI -11.97%

QSIAW -3.13%

QTTB -2.10%

QURE -0.45%

RAIN -1.63%

RANI 6.42%

RAPT -2.89%

RARE 1.58%

RCKT -7.46%

REGN -0.27%

RENB -3.41%

REPL -2.61%

RETA 0.02%

REUN -0.89%

REVB -1.41%

REVBU 3.46%

REVBW 4.38%

RGLS -5.37%

RGNX -5.03%

RIGL -3.28%

RLAY -3.41%

RLMD 0.67%

RLYB -0.67%

RNA 0.36%

RNAC -5.94%

RNAZ -0.63%

RNXT 0.01%

ROIV -1.57%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.22%

RPTX -2.93%

RUBY 2.70%

RVLP -32.05%

RVMD -0.75%

RVMDW -30.00%

RVNC 2.34%

RVPH -1.19%

RVPHW 1.62%

RXDX 0.09%

RXRX -2.77%

RYTM -5.13%

RYZB 0.02%

RZLT 1.56%

SABS -1.37%

SABSW -11.81%

SAGE 1.74%

SANA -2.95%

SAVA -0.60%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH 2.40%

SCPS 0.00%

SEEL -5.28%

SEER 0.88%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO 0.56%

SGMT -2.30%

SGTX -2.56%

SIOX 22.63%

SLDB -6.79%

SLGL 2.97%

SLN -4.40%

SLNO -4.00%

SLRX 6.07%

SLS -2.13%

SMMT -2.12%

SNDX 1.48%

SNGX -4.91%

SNPX -3.84%

SONN -1.08%

SPPI -0.49%

SPRB 0.91%

SPRC -2.75%

SPRO 0.05%

SRNE -34.00%

SRPT -0.70%

SRRA 0.00%

SRRK -1.49%

SRZN -2.45%

STAB 0.00%

STOK -3.94%

STRO -2.62%

STSA 0.00%

STTK -0.70%

SURF -0.93%

SVRA -5.05%

SWTX 0.69%

SYBX -1.29%

SYRS -1.03%

TALS -0.73%

TARA -7.14%

TARS 0.10%

TBPH 0.48%

TCBP 2.48%

TCDA 0.00%

TCON 2.46%

TCRR 0.00%

TCRT 1.59%

TCRX 0.57%

TECH -0.11%

TENX 1.91%

TERN -7.86%

TFFP -5.33%

TGTX -2.97%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -2.59%

TNGX -2.59%

TNXP -4.81%

TNYA -4.38%

TPST 2.91%

TRDA -4.64%

TRVI 2.30%

TRVN 2.97%

TSHA -22.31%

TSVT -3.19%

TTNP -7.66%

TVTX 1.13%

TYRA -6.98%

UBX -2.13%

UNCY -3.77%

URGN -1.30%

UTHR -0.28%

VACC 11.36%

VALN -2.89%

VAXX 80.37%

VBIV 0.78%

VBLT -8.77%

VCEL 0.18%

VCNX 10.35%

VCYT -0.70%

VERA -3.35%

VERU -0.34%

VERV -2.58%

VIGL 6.32%

VINC 2.96%

VIR 1.19%

VIRI -1.61%

VIRX 2.40%

VKTX -1.17%

VLON -13.04%

VNDA -2.52%

VOR -2.02%

VRCA 0.14%

VRDN -4.00%

VRNA -1.40%

VRPX 0.38%

VRTX 0.47%

VSTM -0.68%

VTGN -1.05%

VTVT -2.97%

VTYX -1.29%

VXRT -2.93%

VYGR -0.38%

VYNE -4.62%

VYNT 7.78%

WINT -3.24%

WVE -4.40%

XBIO 0.93%

XBIT -0.41%

XCUR 3.58%

XENE -2.44%

XERS 2.14%

XFOR 2.52%

XLO 4.43%

XLRN 0.00%

XNCR 0.67%

XOMA -2.94%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.00%

YMAB -1.63%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.73%

ZNTL -0.36%

ZSAN 0.00%

Correlation (AI algo v.1.1b): Undervalued: 0.07% $3.00 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

immatics biotechnologies Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

immatics biotechnologies Financials

Annual	2023
Revenue:	$54.00M
Gross Profit:	$-64.67M (-119.76 %)
EPS:	$-1.200

FY	2023
Revenue:	$54.00M
Gross Profit:	$-64.67M (-119.76 %)
EPS:	$-1.200

FY	2022
Revenue:	$172.83M
Gross Profit:	$66.05M (38.22 %)
EPS:	$0.550

Financial Reports:

No articles found.

immatics biotechnologies Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

immatics biotechnologies

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes IMA203 that targets solid tumors, which is in Phase 1b clinical trial; IMA203CD8, a cell therapy product that is in Phase 1b clinical trial; IMA204 that targets tumor stroma, which is in preclinical stage; and IMA30x, an allogenic cellular therapy product candidate, which is in preclinical stage. The company also develops TCR Bispecifics products, including IMA401, which is in Phase 1b clinical trial; and IMA402 and IMA403, which are in preclinical stages. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in Tübingen, Germany.